JPRN-UMIN000008184
已完成
未知
Study of sorafenib and radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis - Sorafenib and radiation therapy for hepatocellular carcinoma
Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine0 个研究点目标入组 6 人2012年6月16日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- advanced hepatocellular carcinoma
- 发起方
- Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
- 入组人数
- 6
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\) Refractory pleural effusion or ascites 2\) Encephalopathy 3\) Concurrent disease a) Serious hypertension b) Severe heart disease c) Acute myocardial infarction within 6 months prior to inclusion d) Active double cancer e) Severe mental disorder f) Allergic reaction to iodine contrast material g) Severe drug allergy 4\) Pregnant and lactating females; females of childbearing age unless using effective contraception 5\) Patients who are concluded to be inappropriate to participate in this study by their physicians
结局指标
主要结局
未指定
相似试验
已完成
2 期
Phase II study of sorafenib in patients with advanced hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000002972Kyorin University Hospital80
尚未招募
2 期
Sorafenib as adjuvant to radioiodine therapy in non-medullary thyroid carcinomathyroid carcinoma1005254710014713NL-OMON31009Academisch Medisch Centrum30
进行中（未招募）
1 期
Sorafenib as adjuvant to radioiodine therapy in non-medullary thyroid carcinomaEUCTR2007-002365-13-NLBayer B.V.
Unknown
不适用
Combined Radiotherapy and Sorafenib in Patients With HepatomaHepatocellular CarcinomaNCT01319942China Medical University Hospital45
已完成
2 期
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma MultiformeGlioblastoma MultiformeNCT00544817SCRI Development Innovations, LLC47